TortsProf Blog

Editor: Christopher J. Robinette
Widener Commonwealth Law School

Wednesday, March 22, 2006

The Story of a Drug

In the Pipeline has an interesting story of the development and apparent decline of a new fixed-dose combination drug, BiDil.  The drug in question is particularly interesting for its indication, which is, according to Lowe, probably the first "race-based pharmaceutical":


(Blogging may be slow in the next couple of days; I'm solo dad and my son has an ear infection, it seems.  Hooray!)

Experts & Science | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference The Story of a Drug:


Good luck on the dad front.


Posted by: Dwayne Clark | Mar 22, 2006 3:43:58 PM

Post a comment